Atria Wealth Solutions Inc. Lowers Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Atria Wealth Solutions Inc. trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 41.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 8,891 shares of the medical equipment provider’s stock after selling 6,304 shares during the period. Atria Wealth Solutions Inc.’s holdings in Intuitive Surgical were worth $4,641,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in ISRG. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $26,000. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $33,000. Decker Retirement Planning Inc. purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $36,000. Sierra Ocean LLC purchased a new position in Intuitive Surgical in the 4th quarter worth approximately $40,000. Finally, Capital Performance Advisors LLP purchased a new position in Intuitive Surgical in the 3rd quarter worth approximately $38,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Piper Sandler restated an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. CICC Research began coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They set a “neutral” rating and a $550.00 target price for the company. Citigroup boosted their target price on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research note on Friday, January 24th. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Stifel Nicolaus boosted their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. One analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $608.48 on Thursday. The company has a market capitalization of $216.73 billion, a P/E ratio of 94.93, a P/E/G ratio of 5.74 and a beta of 1.39. The company has a fifty day moving average of $563.17 and a 200 day moving average of $522.88. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 376 shares of the company’s stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the completion of the transaction, the executive vice president now owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This represents a 6.39 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Jamie Samath sold 188 shares of the company’s stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $101,332.00. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,720,023. This represents a 2.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 6,348 shares of company stock valued at $3,587,582. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.